Chikungunya virus disease: An emerging challenge for the rheumatologist

Journal of Clinical Rheumatology

Volumn 22, Issue 4, 2016, Pages 203-211

  Vijayan, Vini ^a   Sukumaran, Sukesh ^b  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIPYRETIC AGENT; C REACTIVE PROTEIN; CHLOROQUINE; CORTICOSTEROID; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; TUMOR NECROSIS FACTOR ANTIBODY;

AEDES AEGYPTI; AEDES ALBOPICTUS; ALPHAVIRUS; ARTHRALGIA; ASTHENIA; BRAIN DISEASE; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; CHRONIC DISEASE; CLINICAL FEATURE; CROSS REACTION; DENGUE; DEPRESSION; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; EDEMA; ENCEPHALITIS; EPISCLERITIS; EYE DISEASE; FATIGUE; FEBRILE CONVULSION; FEVER; FLACCID PARALYSIS; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GUILLAIN BARRE SYNDROME; HEMATEMESIS; HEPATITIS; HUMAN; HYDRATION; HYPERPIGMENTATION; INCIDENCE; INFECTION PREVENTION; IRIDOCYCLITIS; JOINT EFFUSION; LIVER FUNCTION TEST; LYMPHADENOPATHY; MACULOPAPULAR RASH; MELENA; MENINGOENCEPHALITIS; MIXED INFECTION; MORNING STIFFNESS; MORTALITY RATE; MUCOSAL BLEEDING; MULTIPLE ORGAN FAILURE; MYALGIA; MYOCARDITIS; NAUSEA; NEWBORN; NONHUMAN; PAIN; PERCEPTION DEAFNESS; PERIARTICULAR EDEMA; PETECHIA; PHYLOGENY; POINT MUTATION; POLYARTHRITIS; PREGNANT WOMAN; PRIORITY JOURNAL; PURPURA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REST; RETINITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TENOSYNOVITIS; UNITED STATES; VECTOR CONTROL; VIRUS IMMUNITY; VIRUS TRANSMISSION; ANIMAL; CHIKUNGUNYA FEVER; DIFFERENTIAL DIAGNOSIS; EPIDEMIC; GLOBAL HEALTH; MOSQUITO; TRANSMISSION; TRAVEL; VIROLOGY;

ANIMALS; CHIKUNGUNYA FEVER; CULICIDAE; DIAGNOSIS, DIFFERENTIAL; DISEASE OUTBREAKS; GLOBAL HEALTH; HUMANS; TRAVEL;

EID: 84974588479     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0000000000000396     Document Type: Review

References (100)

1. Jupp PG, Monath TP. Chikungunya virus disease. In: Monath TP, ed. The Arboviruses: Epidemiology and Ecology. Vol. II. Boca Raton, FL: CRC Press; 1988. p. 137-157.
2. Ross RW. The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic. J Hyg (Lond). 1956;54: 177-191.
3. Pialoux G, Gauzere B-A, Jaureguiberry S, et al. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis. 2007;7:319-327.
4. Gérardin P, Fianu A, Malvy D, et al. Perceived morbidity and community burden after a chikungunya outbreak: the TELECHIK survey, a population-based cohort study. BMC Med. 2011;9:5.
5. Krishnamoorthy K, Harichandrakumar KT, Krishna Kumari A, et al. Burden of chikungunya in India: estimates of disability adjusted life years (DALY) lost in 2006 epidemic. J Vector Borne Dis. 2009;46:26-35.
6. Staples JE, Breiman RF, Powers AM. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis. 2009;49:942-948.
7. Burt FJ, Rolph MS, Rulli NE, et al. Chikungunya: a re-emerging virus. Lancet. 2012;379:662-671.
8. Fischer M, Staples JE. Arboviral Diseases Branch, National Center for Emerging and Zoonotic Infectious Diseases, CDC. Notes from the field: chikungunya virus spreads in the Americas-Caribbean and South America, 2013-2014. MMWR Morb Mortal Wkly Rep. 2014;63:500-501.
9. Centers for Disease Control and Prevention. Chikungunya virus in the United States. Available at: http://www.cdc.gov/chikungunya/geo/united-states.html. Accessed September 13, 2015.
10. Gibney KB, Fischer M, Prince HE, et al. Chikungunya fever in the United States: a fifteen year review of cases. Clin Infect Dis. 2011;52: e121-e126.
11. Lanciotti RS, Kosoy OL, Laven JJ, et al. Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis. 2007;13:764-767.
12. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569-2581.
13. Bouquillard E, Combe B. Rheumatoid arthritis after chikungunya fever: a prospective follow-up study of 21 cases. Ann Rheum Dis. 2009;68: 1505-1506.
14. Lumsden WH. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. II. General description and epidemiology. Trans R Soc Trop Med Hyg. 1955;49:33-57.
15. Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features. Trans R Soc Trop Med Hyg. 1955;49:28-32.
16. Muyembe-Tamfum JJ, Peyrefitte CN, Yogolelo R, et al. Epidemic of chikungunya virus in 1999 and 2000 in the Democratic Republic of the Congo. Med Trop. 2003;63:637-638.
17. Powers AM, Logue CH. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol. 2007;88(pt 9): 2363-2377.
18. Halstead SB, Scanlon JE, Umpaivit P, et al. Dengue and chikungunya virus infection in man in Thailand, 1962-1964 IV. Epidemiologic studies in the Bangkok metropolitan area. Am J Trop Med Hyg. 1969;18: 997-1021.
19. Kariuki Njenga M, Nderitu L, Ledermann JP, et al. Tracking epidemic chikungunya virus into the Indian Ocean from East Africa. J Gen Virol. 2008;89:2754-2760.
20. Sergon K, Njuguna C, Kalani R, et al. Seroprevalence of chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am J Trop Med Hyg. 2008;78:333.
21. Sergon K, Yahaya AA, Brown J, et al. Seroprevalence of chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005. Am J Trop Med Hyg. 2007;76:1189-1193.
22. Sissoko D, Moendandze A, Malvy D, et al. Seroprevalence and risk factors of chikungunya virus infection in Mayotte, Indian Ocean, 2005-2006: a population-based survey. PLoS One. 2008;3:e3066.
23. Beesoon S, Funkhouser E, Kotea N, et al. Chikungunya fever, Mauritius, 2006. Emerg Infect Dis. 2008;14:337-338.
24. Paquet C, Quatresous I, Solet JL, et al. Chikungunya outbreak in Reunion: epidemiology and surveillance, 2005 to early January 2006. Euro Surveill. 2006;11:E060202.3.
25. Renault P, Solet JL, Sissoko D, et al. A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006. Am J Trop Med Hyg. 2007;77:727-731.
26. Tsetsarkin KA, Vanlandingham DL, McGee CE, et al. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007;3:e201.
27. Dash PK, Parida MM, Santhosh SR, et al. East Central South African genotype as the causative agent in reemergence of chikungunya outbreak in India. Vector Borne Zoonotic Dis. 2007;7:519-527.
28. Mavalankar D, Shastri P, Raman P. Chikungunya epidemic in India: a major public-health disaster. Lancet Infect Dis. 2007;7:306-307.
29. Krastinova E1, Quatresous I, Tarantola A. Imported cases of chikungunya in metropolitan France: update to June 2006. Euro Surveill. 2006; 11:E060824.1.
30. Panning M, Grywna K, van Esbroeck M, et al. Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006. Emerg Infect Dis. 2008;14:416-422.
31. Lindsey NP, Prince HE, Kosoy O, et al. Chikungunya virus infections among travelers-United States, 2010-2013. Am J Trop Med Hyg. 2015;92:82-87.
32. Angelini R, Finarelli AC, Angelini P, et al. An outbreak of chikungunya fever in the province of Ravenna, Italy. Euro Surveill. 2007;12:E070906.1.
33. Grandadam M, Caro V, Plumet S, et al. Chikungunya virus, southeastern France. Emerg Infect Dis. 2011;17:910-913.
34. Cassadou S, Boucau S, Petit-Sinturel M, et al. Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013. Euro Surveill. 2014;19.
35. Pan American Health Organization and CDC. Preparedness and Response for Chikungunya Virus Introduction in the Americas. Washington, DC: Pan American Health Organization; 2011. Available at: http://new.paho.org/hq/index.php?option=com-content&view= article&id=3545&Itemid=2545&lang=en.
36. Vega-Rua A, Zouache K, Girod R, et al. High level of vector competence of Aedes aegypti and Aedes albopictus from ten American countries as a crucial factor in the spread of chikungunya virus. J Virol. 2014;88: 6294-6306.
37. Powers AM, Brault AC, Tesh RB, et al. Re-emergence of chikungunya and o'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol. 2000;81(pt 2): 471-479.
38. Inoue S, Morita K, Matias RR, et al. Distribution of three arbovirus antibodies among monkeys (Macaca fascicularis) in the Philippines. J Med Primatol. 2003;32:89-94.
39. Ramful D, Carbonnier M, Pasquet M, et al. Mother-to-child transmission of chikungunya virus infection. Pediatr Infect Dis J. 2007;26:811-815.
40. Parola P, de Lamballerie X, Jourdan J, et al. Novel chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis. 2006;12:1493-1499.
41. Couderc T, Gangneux N, Chretien F, et al. Chikungunya virus infection of corneal grafts. J Infect Dis. 2012;206:851-85915.
42. Brouard C, Bernillon P, Quatresous I, et al. Estimated risk of chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007. Transfusion. 2008;48:1333.
43. Reiter P, Fontenille D, Paupy C. Aedes albopictus as an epidemic vector of chikungunya virus: another emerging problem? Lancet Infect Dis. 2006;8:463-464.
44. Benedict MQ, Levine RS, Hawley WA, et al. Spread of the tiger: global risk of invasion by the mosquito Aedes albopictus. Vector Borne Zoonotic Dis. 2007;7:76-85.
45. Rochlin I, Ninivaggi DV, Hutchinson ML, et al. Climate change and range expansion of the Asian tiger mosquito (Aedes albopictus) in Northeastern USA: implications for public health practitioners. PLoS One. 2013;8:e60874.
46. Rudolph KE, Lessler J, Moloney RM, et al. Incubation periods of mosquito-borne viral infections: a systematic review. Am J Trop Med Hyg. 2014;90:882-891.
47. Thiberville SD, Boisson V, Gaudart J, et al. Chikungunya fever: a clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean. PLoS Negl Trop Dis. 2013;7:e2004.
48. Taubitz W, Cramer JP, Kapaun A, et al. Chikungunya fever in travelers: clinical presentation and course. Clin Infect Dis. 2007;45:e1-e4.
49. Suhrbier A, Jaffar-Bandjee MC, Gasque P. Arthritogenic alphaviruses-an overview. Nat Rev Rheumatol. 2012;8:420-429.
50. Brighton SW, Prozesky OW, de la Harpe AL. Chikungunya virus infection. A retrospective study of 107 cases. S Afr Med J. 1983;63: 313-315.
51. Borgherini G, Poubeau P, Staikowsky F, et al. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis. 2007;44:1401-1407.
52. Hochedez P, Jaureguiberry S, Debruyne M, et al. Chikungunya infection in travelers. Emerg Infect Dis. 2006; 12:1565-1567.
53. Parola P, Simon F, Oliver M. Tenosynovitis and vascular disorders associated with chikungunya virus-related rheumatism. Clin Infect Dis. 2007;45:801-802.
54. Prashant S, Kumar AS, Mohammed Basheeruddin DD, et al. Cutaneous manifestations in patients suspected of chikungunya disease. Indian J Dermatol. 2009;54:128-131.
55. Inamadar AC, Palit A, Sampagavi VV, et al. Cutaneous manifestations of chikungunya fever: observations made during a recent outbreak in south India. Int J Dermatol. 2008;47:154-159.
56. Bandyopadhyay D, Ghosh SK. Mucocutaneous features of chikungunya fever: a study from an outbreak in West Bengal India. Int J Dermatol. 2008;47:1148-1152.
57. Mishra K, Rajawat V. Chikungunya-induced genital ulcers. Indian J Dermatol Venereol Leprol. 2008;74:383-384.
58. Mahendradas P, Ranganna SK, Shetty R, et al. Ocular manifestations associated with chikungunya. Ophthalmology. 2008;115:287-291.
59. Sissoko D, Malvy D, Ezzedine K, et al. Postepidemic chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis. 2009;3:e389.
60. Lynch N, Ellis Pegler R. Persistent arthritis following chikungunya virus infection. N Z Med J. 2010;123:79-81.
61. Schilte C, Staikowsky F, Couderc T, et al. Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis. 2013;7:e2137.
62. Simon F, Parola P, Grandadam M, et al. Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine (Baltimore). 2007;86:123-137.
63. Brighton SW, Simson IW. A destructive arthropathy following chikungunya virus arthritis-a possible association. Clin Rheumatol. 1984;3:253-258.
64. Malvy D, Ezzedine K, Mamani-Matsuda M, et al. Destructive arthritisin a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect Dis. 2009;9:200.
65. Miner JJ, Aw Yeang HX, Fox JM, et al. Brief report: chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol. 2015;67:1214-1220.
66. Javelle E, Ribera A, Degasne I, et al. Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006-2012. PLoS Negl Trop Dis. 2015; 9:e0003603.
67. Chopra A, Anuradha V, Lagoo-Joshi V, et al. Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum. 2008;58: 2921-2922.
68. Manimunda SP, Vijayachari P, Uppoor R, et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg. 2010;104:392-399.
69. Josseran L, Paquet C, Zehgnoun A, et al. Chikungunya disease outbreak Reunion Island. Emerg Infect Dis. 2006;12:1994-1995.
70. Rajapakse S, Rodrigo C, Rajapakse A. Atypical manifestations of chikungunya infection. Trans R Soc Trop Med Hyg. 2010;104:89-96.
71. Lemant J, Boisson V, Winer A, et al. Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006. Crit Care Med. 2008;36:2536-2541.
72. Wielanek AC, Monredon JD, Amrani ME, et al. Guillain-Barré syndrome complicating a chikungunya virus infection. Neurology. 2007;69: 2105-2107.
73. Singh SS, Manimunda SP, Sugunan AP, et al. Four cases of acute flaccid paralysis associated with chikungunya virus infection. Epidemiol Infect. 2008;136:1277-1280.
74. Ezzedine K, Cazanave C, Pistone T, et al. Dual infection by chikungunya virus and other imported infectious agent in a traveler returning from India. Travel Med Infect Dis. 2008;6:152-154.
75. Lee VJ, Chow A, Zheng X, et al. Simple clinical and laboratory predictors of chikungunya versus dengue infections in adults. PLoS Negl Trop Dis. 2012;6:e1786.
76. Gerardin P, Barau G, Michault A, et al. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Reunion. PLoS Med. 2008;5:e60.
77. Valamparampil JJ, Chirakkarot S, Letha S, et al. Clinical profile of chikungunya in infants. Indian J Pediatr. 2009;76:151-155.
78. Pellot AS, Alessandri JL, Robin S, et al. Severe forms of chikungunya virus infection in a pediatric intensive care unit on Reunion Island. Med Trop (Mars). 2012;72:Spec No:88-93.
79. Le Bomin A, Hebert JC, Marty P, et al. Confirmed chikungunya in children in Mayotte. Description of 50 patients hospitalized from February to June 2006. Med Trop (Mars). 2008;68:491-495.
80. Robin S, Ramful D, Le Seach F, et al. Neurologic manifestations of pediatric chikungunya infection. J Child Neurol. 2008;23:1028-1035.
81. Lewthwaite P, Vasanthapuram R, Osborne JC, et al. Chikungunya virus and central nervous system infections in children India. Emerg Infect Dis. 2009;15:329-331.
82. Hochedez P, Canestri A, Guihot A, et al. Management of travelers with fever and exanthema, notably dengue and chikungunya infections. Am J Trop Med Hyg. 2008;78:710-713.
83. Lakshmi V, Neeraja M, Subbalaxmi MV, et al. Clinical features and molecular diagnosis of chikungunya fever from South India. Clin Infect Dis. 2008;46:1436-1446.
84. Pan American Health Organization/Centers for Disease Control and Prevention (PAHO/CDC). Preparedness and response for chikungunya virus. Introduction in the Americas 2011. Available at: http://www.paho. org/hq/index.php?option=com-content&view=article&id= 3545&Itemid=40377&lang=e. Accessed April 1, 2015.
85. Grivard P1, Le Roux K, Laurent P, et al. Molecular and serological diagnosis of chikungunya virus infection. Pathol Biol (Paris). 2007;55: 490-494.
86. Litzba N, Schuffenecker I, Zeller H, et al. Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. J Virol Methods. 2008;149:175-179.
87. Briolant S, Garin D, Scaramozzino N, et al. In vitro inhibition of chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. Antiviral Res. 2004;61:111-117.
88. de Lamballerie X, Ninove L, Charrel RN. Antiviral treatment of chikungunya virus infection. Infect Disord Drug Targets. 2009;9: 101-104.
89. Brighton SW. Chloroquine phosphate treatment of chronic chikungunya arthritis. An open pilot study. S Afr Med J. 1984;66:217-218.
90. Chopra A, Saluja M, Venugopalan A. Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol. 2014;66:319-326.
91. Zaid A1, Rulli NE, Rolph MS, et al. Disease exacerbation by etanercept in a mouse model of alphaviral arthritis and myositis. Arthritis Rheum. 2011;63:488-491.
92. Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, et al. Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol. 2010;184:5914-5927.
93. Ganu MA, Ganu AS. Post-chikungunya chronic arthritis-our experience with DMARDs over two year follow up. J Assoc Physicians India. 2011;59:83-86.
94. Ribéra A1, Degasne I, Jaffar Bandjee MC, et al. Chronic rheumatic manifestations following chikungunya virus infection: clinical description and therapeutic considerations. Med Trop (Mars). 2012;72spec no:83-85.
95. Weaver SC, Osorio JE, Livengood JA, et al. Chikungunya virus and prospects for a vaccine [review]. Expert Rev Vaccines. 2012;11: 1087-1101.
96. Edelman R, Tacket CO, Wasserman SS, et al. Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg. 2000;62:681.
97. Akahata W, Yang ZY, Andersen H, et al. Avirus-like particle vaccine for epidemic chikungunya virus protects nonhuman primates against infection. Nat Med. 2010;16:334.
98. Couderc T, Khandoudi N, Grandadam M, et al. Prophylaxis and therapy for chikungunya virus infection. J Infect Dis. 2009;200: 516-523.
99. Fric J, Bertin-Maghit S, Wang CI, et al. Use of human monoclonal antibodies to treat chikungunya virus infection. J Infect Dis. 2013;207: 319-322.
100. Pal P, Dowd KA, Brien JD, et al. Development of a highly protective combination monoclonal antibody therapy against chikungunya virus. PLoS Pathog. 2013;9:e1003312.